Budget Increase For NIH Won't Meet Expectations

WASHINGTON--The 6 percent increase requested for the National Institutes of Health in 1992 would provide enough funds to support 632 more research grants but not enough, say science policy analysts, to put federally supported biomedical research on firm financial footing. Given the sorry state of the economy and the huge federal deficit, scientists as well as members of Congress are praising the president's proposed $8.78 billion NIH budget as a step in the right direction. But agency official

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Given the sorry state of the economy and the huge federal deficit, scientists as well as members of Congress are praising the president's proposed $8.78 billion NIH budget as a step in the right direction. But agency officials say it's not large enough to allow them to fund at least 6,000 new grants each year, a goal that Congress has urged NIH to adopt and that many researchers feel is vital to the continued health of academic biomedical science (The Scientist, Sept. 3, 1990, page 1; and Jan. 7, 1991, page 6). During the past decade, NIH has stretched its research dollar by levying across-the-board cuts, called downward negotiations, on grants already approved for funding. Each year the average percentage cut has risen, reaching nearly 15 percent last year. At that point, Congress issued a call to stop this practice.

NIH officials have complied. From now on, says acting NIH ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Elizabeth Pennisi

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo